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Abstrakt: 
-cyclodextrin – a weight loss agent? 
 
Lisbeth Hansen, Ditte Sørensen, Nirooshitha Ganesaratnam, Ludmilla Lumholdt Riisager 
and Kim Lambertsen Larsen
 
Section of Chemistry, Department of Biotechnology, Chemistry and Environmental Engineering, Aalborg 
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In recent years, an alarming increase in overweight, obesity and the following diseases has been 
observed. Unfortunately, the current pharmacological treatments lack effectiveness or display a 
severe side effect profile
v
. New improved drugs against overweight and obesity are therefore 
desirable. In USA and Canada, α-CD is marketed as a dietary fibre and used as a weight loss 
supplement (Mirafit FBCx™, Alpha-Fibe FBCx™). Moreover, a study has shown that adding α-CD 
to a diet resulted in greater weight loss compared to placebo
ii
 and in another study α-CD prevented 
weight gain
iii
. The underlying mechanism for α-CDs possible weight loss ability is still to be 
accounted for. Findings from two studies show that α-CD can significantly lower the post-prandial 
plasma glucose response after a starch-rich meal
i, iv
. It is therefore hypothesized that α-CD inhibits 
the enzymatic degradation of starch, which this study aims to investigate further. 
γ-cyclodextrin (γ-CD) and a starch solution was chosen as substrates. The hydrolysis by porcine 
pancreatic α-amylase (PPA) in the presence of α-CD was monitored at 37°C, pH 6.5. The 
degradation reactions were followed over time by quantification of the amount of reducing ends as 
maltose equivalents. The hydrolysis of γ-CD revealed that the presence of α-CD inhibited the 
enzymatic degradation in a dose-dependent manner. α-CD in a molar ratio of  0.2:1 (α-CD:γ-CD) 
was not sufficient to inhibit the degradation, whereas α-CD in a molar ratio of 1:1 showed some 
effect since the initial degradation rate decreased (from 4.6 mM/hour for the control (no α-CD 
present) to 4.0 mM/hour). In ratio 5:1 the degradation rate was almost 50% less (2.4 mM/hour). 
Lastly, the initial degradation rates in ratio 15:1 and 20:1 were only one third (1.2 mM/hour) of 
what was observed in the absence of α-CD. These results shows that α-CD is capable of inhibiting 
the enzymatic degradation of γ-CD considerably and that there might be an upper limit to the 
inhibitory effect.  
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